Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Taro Pharm Inds (TARO)

116.06 +2.04 (+1.79%)

6/23/2017  4:02pm

Open:

114.23

Pre. Close:

114.02

High:

116.87

Low:

111.44

Volume:

44,295

Market Cap:

4.71B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

117.23 - 118.16

118.16 - 119.48

Low:

110.24 - 110.56

110.56 - 111.02

Close:

115.32 - 116.49

116.49 - 118.14

Technical analysis  (as of: 2017-06-23 4:38:46 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 136.81     One year: 159.79

Support:

Support1: 108.10    Support2: 102.52

Resistance:

Resistance1: 117.13    Resistance2: 136.81

Pivot:

109.57

Moving Averages:

MA(5): 113.67     MA(20): 108.40

MA(100): 113.14     MA(250): 115.90

MACD:

MACD(12,26): 0.62     Signal(12,26,9): -0.64

%K %D:

%K(14,3): 88.40     %D(3): 89.52

RSI:

RSI(14): 63.41

52-Week:

High: 148.00  Low: 92.28  Change(%): -19.2

Average Vol(K):

3-Month: 73  10-Days 59

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TARO has closed below upper band by 4.0%. Bollinger Bands are 36.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 09 Jun 2017 06:20:15 GMT
The Long Case For Taro Pharmaceutical

Tue, 13 Jun 2017 14:56:07 GMT
Taro Pharmaceuticals: Positioning To Negotiate With Dilip Shanghvi

Tue, 23 May 2017 18:22:30 GMT
Taro Pharmaceutical Industries' (TARO) Interim CEO Abhay Gandhi on Q4 2017 ...

Thu, 28 Jul 2016 17:03:45 GMT
Taro Pharma: Seeking A Catalyst

Fri, 23 Jun 2017 23:15:00 GMT
Taro Pharmaceutical Industries (TARO) Earns Media Sentiment Rating of 0.10

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

41.03

Shares Float (M)

11.40

% Held by Insiders

% Held by Institutions

Shares Short (K)

2470

Shares Short Prior Month (K)

2460

Stock Financials

EPS

11.050

EPS Est. Current Year

11.000

EPS Est. Next Year

10.040

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

50.970

PEG Ratio

Profit Margin

51.89

Operating Margin

58.59

Return on Assets (ttm)

14.4

Return on Equity (ttm)

22.8

Qtrly Rev. Growth

-25.9

Gross Profit (p.s.)

18.985

Sales Per Share

EBITDA (p.s.)

12.919

Qtrly Earnings Growth

-27.80

Operating Cash Flow (M)

437.54

Levered Free Cash Flow (M)

310.61

FoxReading.com

Valuation

P/E

10.50

P/E Growth Ratio

0.02

P/BV

2.28

P/S

223670352.00

P/CF

10.88

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.